Welcome to ELIXIR
"ELIXIR unites Europe’s leading life science organisations in managing and safeguarding the massive amounts of data being generated every day by publicly funded research. It is a pan-European research infrastructure for biological information. ELIXIR will provide the facilities necessary for life science researchers - from bench biologists to cheminformaticians - to make the most of our rapidly growing store of information about living systems, which is the foundation on which our understanding of life is built."
Coordinator, ELIXIR preparatory phase
Director, EMBL-EBI
-
Sir Paul Nurse:"Open access to the genomes of well-characterised organisms, such as those of yeast, fruit fly and mouse, is crucial for biomedical research. ELIXIR will..."
Read more -
Sir Mark Walport:"It is vitally important for Europe that significant investment in bioinformatics is given the highest priority. Investment in bioinformatics services is..."
Read more -
Prof. Dr. Gert van Ommen:"As co-initiator of BBMRI and leader of CMSB, I am closely familiar with the complex issues of facilitating access to state-of-the-art bioinformatics..."
Read more -
Professor Mike Stratton:"Over the next few years, our group at the Sanger Institute, and others around the globe as part of the International Cancer Genome Consortium, will be..."
Read more -
Professor Douglas Kell:"High-throughput biology is a disruptive technology: computer storage and processor capacity double steadily every couple of years, whereas new biological..."
Read more -
Professor Sir John Sulston:"One of Europe’s greatest challenges in the future will be managing the interpretation of personal genomic data; it is unlikely that personal genome..."
Read more -
Choo Chiap Chiau:"With so much data being produced all the time, companies need to share ideas and feed into how the data can be accessed. We can't work in isolation anymore..."
Read more -
Dr Mark Forster:"The ELIXIR project will shape the future of Europe's open access to life science bio-molecular data. The benefits to industry should manifest themselves in..."
Read more
Latest news
ELIXIR took several important steps forward at its Interim Board meeting in Copenhagen on 22-23 April 2013.
Most notably, ELIXIR Member States agreed the final version of the ELIXIR Consortium Agreement (ECA), which is the permanent legal basis for ELIXIR. The ECA will now undergo a...
Contact us
ELIXIR Office
EMBL-European Bioinformatics Institute
Wellcome Trust Genome Campus
Hinxton, Cambridgeshire
CB10 1SD, United Kingdom
+44 (0)1223 494-444
+44 (0)1223 494-468
elixirpm@ebi.ac.uk